PEDIATRIC LATE OUTCOMES PROTOCOL ACTG 219C

点击翻译按钮获取中文摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to follow all infants, children and adolescents who are seen at Pediatric AIDS Clinical Trials Group sites as well as infants born to HIV-infected mothers who were enrolled in a PACTG drug study when they were pregnant, to look for long-term benefits or any late, harmful effects of medications or vaccines taken. All children are eligible to be followed until at least their 24th birthday.